Johnson & Johnson ROE 1986-2025 | JNJ
Current and historical return on equity (ROE) values for Johnson & Johnson (JNJ) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Johnson & Johnson ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2025-09-30 |
$25.12B |
|
44.05% |
| 2025-06-30 |
$22.66B |
$78.47B |
30.39% |
| 2025-03-31 |
$21.81B |
$78.11B |
29.95% |
| 2024-12-31 |
$14.07B |
$71.49B |
19.87% |
| 2024-09-30 |
$14.68B |
$70.16B |
20.94% |
| 2024-06-30 |
$38.02B |
$71.54B |
54.01% |
| 2024-03-31 |
$38.48B |
$70.02B |
53.73% |
| 2023-12-31 |
$35.15B |
$68.77B |
48.95% |
| 2023-09-30 |
$34.62B |
$71.23B |
46.90% |
| 2023-06-30 |
$13.05B |
$76.41B |
17.48% |
| 2023-03-31 |
$12.72B |
$70.87B |
17.04% |
| 2022-12-31 |
$17.94B |
$76.80B |
23.73% |
| 2022-09-30 |
$19.16B |
$74.60B |
25.57% |
| 2022-06-30 |
$18.37B |
$76.36B |
24.87% |
| 2022-03-31 |
$19.83B |
$74.71B |
27.49% |
| 2021-12-31 |
$20.88B |
$74.02B |
29.86% |
| 2021-09-30 |
$17.88B |
$70.27B |
26.59% |
| 2021-06-30 |
$17.77B |
$69.58B |
27.01% |
| 2021-03-31 |
$15.12B |
$65.83B |
23.57% |
| 2020-12-31 |
$14.71B |
$63.28B |
23.35% |
| 2020-09-30 |
$16.99B |
$64.47B |
27.37% |
| 2020-06-30 |
$15.19B |
$62.98B |
25.10% |
| 2020-03-31 |
$17.17B |
$61.29B |
28.64% |
| 2019-12-31 |
$15.12B |
$59.47B |
25.47% |
| 2019-09-30 |
$14.15B |
$58.21B |
23.81% |
| 2019-06-30 |
$16.33B |
$60.79B |
26.76% |
| 2019-03-31 |
$14.68B |
$58.96B |
23.85% |
| 2018-12-31 |
$15.30B |
$59.75B |
24.42% |
| 2018-09-30 |
$1.54B |
$64.63B |
2.46% |
| 2018-06-30 |
$1.37B |
$62.89B |
2.11% |
| 2018-03-31 |
$1.25B |
$63.26B |
1.85% |
| 2017-12-31 |
$1.30B |
$60.16B |
1.88% |
| 2017-09-30 |
$15.83B |
$73.98B |
22.08% |
| 2017-06-30 |
$16.34B |
$71.92B |
22.89% |
| 2017-03-31 |
$16.51B |
$70.34B |
23.08% |
| 2016-12-31 |
$16.54B |
$70.42B |
22.95% |
| 2016-09-30 |
$15.94B |
$72.77B |
22.06% |
| 2016-06-30 |
$15.03B |
$72.47B |
20.88% |
| 2016-03-31 |
$15.55B |
$72.65B |
21.71% |
| 2015-12-31 |
$15.41B |
$71.15B |
21.88% |
| 2015-09-30 |
$14.72B |
$71.55B |
21.00% |
| 2015-06-30 |
$16.11B |
$71.13B |
22.58% |
| 2015-03-31 |
$15.92B |
$67.88B |
21.78% |
| 2014-12-31 |
$16.32B |
$69.75B |
21.69% |
| 2014-09-30 |
$17.32B |
$76.59B |
22.70% |
| 2014-06-30 |
$15.55B |
$78.05B |
20.84% |
| 2014-03-31 |
$15.06B |
$76.58B |
20.77% |
| 2013-12-31 |
$13.83B |
$74.05B |
19.73% |
| 2013-09-30 |
$12.88B |
$69.80B |
19.00% |
| 2013-06-30 |
$12.87B |
$69.67B |
19.41% |
| 2013-03-31 |
$10.44B |
$66.86B |
16.32% |
| 2012-12-31 |
$10.85B |
$64.83B |
17.34% |
| 2012-09-30 |
$8.50B |
$63.76B |
14.02% |
| 2012-06-30 |
$8.74B |
$60.43B |
14.54% |
| 2012-03-31 |
$10.11B |
$61.37B |
16.70% |
| 2011-12-31 |
$9.67B |
$57.08B |
16.08% |
| 2011-09-30 |
$11.40B |
$61.53B |
18.99% |
| 2011-06-30 |
$11.61B |
$62.13B |
19.69% |
| 2011-03-31 |
$12.28B |
$59.86B |
21.69% |
| 2010-12-31 |
$13.33B |
$56.58B |
24.28% |
| 2010-09-30 |
$13.60B |
$57.29B |
25.46% |
| 2010-06-30 |
$13.53B |
$52.85B |
26.17% |
| 2010-03-31 |
$13.29B |
$52.91B |
26.55% |
| 2009-12-31 |
$12.27B |
$50.59B |
25.69% |
| 2009-09-30 |
$12.77B |
$50.38B |
27.93% |
| 2009-06-30 |
$12.74B |
$46.25B |
28.58% |
| 2009-03-31 |
$12.86B |
$43.79B |
28.82% |
| 2008-12-31 |
$12.95B |
$42.51B |
28.73% |
| 2008-09-30 |
$12.61B |
$45.73B |
27.85% |
| 2008-06-30 |
$11.85B |
$46.44B |
26.48% |
| 2008-03-31 |
$11.60B |
$45.63B |
26.42% |
| 2007-12-31 |
$10.58B |
$43.32B |
24.75% |
| 2007-09-30 |
$10.37B |
$43.57B |
24.85% |
| 2007-06-30 |
$10.58B |
$43.12B |
25.82% |
| 2007-03-31 |
$10.32B |
$40.93B |
25.55% |
| 2006-12-31 |
$11.05B |
$39.32B |
27.33% |
| 2006-09-30 |
$10.98B |
$40.57B |
27.25% |
| 2006-06-30 |
$10.76B |
$40.74B |
27.34% |
| 2006-03-31 |
$10.53B |
$41.12B |
27.73% |
| 2005-12-31 |
$10.06B |
$38.71B |
27.87% |
| 2005-09-30 |
$8.85B |
$36.85B |
25.76% |
| 2005-06-30 |
$8.66B |
$35.17B |
26.20% |
| 2005-03-31 |
$8.53B |
$33.65B |
26.85% |
| 2004-12-31 |
$8.18B |
$31.81B |
26.85% |
| 2004-09-30 |
$9.14B |
$31.51B |
31.26% |
| 2004-06-30 |
$8.87B |
$30.05B |
31.91% |
| 2004-03-31 |
$7.62B |
$28.49B |
28.88% |
| 2003-12-31 |
$7.20B |
$26.87B |
28.48% |
| 2003-09-30 |
$6.74B |
$25.74B |
27.80% |
| 2003-06-30 |
$6.39B |
$24.44B |
27.40% |
| 2003-03-31 |
$6.83B |
$24.04B |
30.13% |
| 2002-12-31 |
$6.60B |
$22.70B |
29.19% |
| 2002-09-30 |
$6.32B |
$22.09B |
27.49% |
| 2002-06-30 |
$6.12B |
$21.89B |
26.17% |
| 2002-03-31 |
$5.95B |
$23.72B |
25.21% |
| 2001-12-31 |
$5.67B |
$24.23B |
24.98% |
| 2001-09-30 |
$5.45B |
$23.73B |
25.10% |
| 2001-06-30 |
$5.25B |
$22.71B |
25.70% |
| 2001-03-31 |
$5.13B |
$20.09B |
26.66% |
| 2000-12-31 |
$4.89B |
$20.40B |
26.43% |
| 2000-09-30 |
$4.75B |
$18.49B |
27.23% |
| 2000-06-30 |
$4.54B |
$17.98B |
27.23% |
| 2000-03-31 |
$4.34B |
$17.15B |
27.36% |
| 1999-12-31 |
$4.17B |
$16.21B |
27.52% |
| 1999-09-30 |
$3.52B |
$15.38B |
24.27% |
| 1999-06-30 |
$3.37B |
$14.74B |
23.85% |
| 1999-03-31 |
$3.22B |
$14.22B |
23.41% |
| 1998-12-31 |
$3.00B |
$13.59B |
22.39% |
| 1998-09-30 |
$3.53B |
$13.94B |
26.95% |
| 1998-06-30 |
$3.42B |
$13.31B |
27.02% |
| 1998-03-31 |
$3.31B |
$12.81B |
27.01% |
| 1997-12-31 |
$3.30B |
$12.36B |
27.85% |
| 1997-09-30 |
$3.23B |
$12.18B |
28.13% |
| 1997-06-30 |
$3.12B |
$11.72B |
28.14% |
| 1997-03-31 |
$3.01B |
$11.17B |
28.01% |
| 1996-12-31 |
$2.89B |
$10.84B |
27.77% |
| 1996-09-30 |
$2.80B |
$10.68B |
28.11% |
| 1996-06-30 |
$2.67B |
$10.24B |
28.08% |
| 1996-03-31 |
$2.54B |
$9.83B |
27.94% |
| 1995-12-31 |
$2.40B |
$9.05B |
27.94% |
| 1995-09-30 |
$2.32B |
$8.91B |
28.52% |
| 1995-06-30 |
$2.22B |
$8.56B |
29.03% |
| 1995-03-31 |
$2.12B |
$7.88B |
29.58% |
| 1994-12-31 |
$2.01B |
$7.12B |
29.91% |
| 1994-09-30 |
$1.96B |
$6.99B |
31.07% |
| 1994-06-30 |
$1.89B |
$6.62B |
31.56% |
| 1994-03-31 |
$1.83B |
$6.09B |
31.71% |
| 1993-12-31 |
$1.79B |
$5.57B |
31.75% |
| 1993-09-30 |
$1.76B |
$5.70B |
31.82% |
| 1993-06-30 |
$1.72B |
$5.71B |
30.71% |
| 1993-03-31 |
$1.68B |
$5.54B |
29.93% |
| 1992-12-31 |
$1.65B |
$5.17B |
29.19% |
| 1992-09-30 |
$1.62B |
$5.97B |
28.05% |
| 1992-06-30 |
$1.57B |
$5.71B |
27.91% |
| 1992-03-31 |
$1.52B |
$5.74B |
27.89% |
| 1991-12-31 |
$1.46B |
$5.63B |
27.86% |
| 1991-09-30 |
$1.42B |
$5.36B |
28.03% |
| 1991-06-30 |
$1.37B |
$5.06B |
27.91% |
| 1991-03-31 |
$1.32B |
$4.93B |
27.56% |
| 1990-12-31 |
$1.14B |
$4.90B |
24.75% |
| 1990-09-30 |
$1.11B |
$4.74B |
25.14% |
| 1990-06-30 |
$1.07B |
$4.55B |
25.19% |
| 1990-03-31 |
$1.01B |
$4.29B |
25.04% |
| 1989-12-31 |
$1.08B |
$4.15B |
28.01% |
| 1989-09-30 |
$1.06B |
$3.93B |
28.72% |
| 1989-06-30 |
$1.04B |
$3.75B |
28.87% |
| 1989-03-31 |
$1.01B |
$3.62B |
28.45% |
| 1988-12-31 |
$0.97B |
$3.50B |
27.28% |
| 1988-09-30 |
$0.95B |
$3.51B |
26.73% |
| 1988-06-30 |
$0.92B |
$3.60B |
26.29% |
| 1988-03-31 |
$0.88B |
$3.67B |
25.76% |
| 1987-12-31 |
$0.83B |
$3.49B |
25.72% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
